Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
55.07 +1.26    +2.34%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
55.27
+0.20
+0.36%
19:59:31 - Real-time Data
  • Volume: 997,598
  • Bid/Ask: 55.00 / 55.35
  • Day's Range: 53.99 - 55.34
Type:  Equity
Market:  United States
Crispr Therapeutics 55.07 +1.26 +2.34%

CRSP Recent Sentiments

 
This page features our users' sentiments regarding the Crispr Therapeutics AG stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 30, 2024 Erhard Muschaweck   53.07 +3.77%
Apr 29, 2024 Ersin Sener   55.26 +0.34%
Apr 26, 2024 Bruno Schuler   53.85 Apr 29, 2024 @ 55.26 +2.62%
Apr 25, 2024 Mundo Koh   53.11 Apr 25, 2024 @ 53.41 +0.56%
Apr 25, 2024 Manuel Barbosa Moura   52.99 +3.93%
Apr 23, 2024 gimmyx gas   56.48 -2.50%
Apr 23, 2024 João Santos   56.79 Apr 29, 2024 @ 55.26 -2.69%
Apr 23, 2024 Lin Tayar   57.89 +4.87%
Apr 19, 2024 Mubariz Eliyev   55.31 Apr 22, 2024 @ 55.02 -0.52%
Apr 18, 2024 Florin M Pop   55.53 Apr 22, 2024 @ 55.02 -0.92%
Apr 16, 2024 제윤 모   58.69 Apr 22, 2024 @ 55.02 -6.25%
Apr 12, 2024 Florin M Pop   62.53 Apr 15, 2024 @ 60.41 -3.39%
Apr 11, 2024 Jörg Holl   61.11 Apr 15, 2024 @ 60.41 -1.15%
Apr 11, 2024 Franz Josef Wielath   62.00 Apr 15, 2024 @ 60.41 +2.56%
Apr 10, 2024 Radagast el pardo   60.92 -9.60%
Apr 10, 2024 Mark Pycroft   60.77 -9.38%
Apr 08, 2024 אילון אילון   63.24 Apr 08, 2024 @ 63.34 -0.16%
Apr 05, 2024 חיים פקר   62.83 Apr 26, 2024 @ 53.91 -14.20%
Apr 04, 2024 La Paul   66.28 Apr 26, 2024 @ 53.91 -18.66%
Apr 04, 2024 지우 황   66.45 Apr 26, 2024 @ 53.91 -18.87%
Apr 04, 2024 Florin M Pop   64.60 Apr 08, 2024 @ 63.34 -1.95%
Apr 03, 2024 אביהו פנחס   64.85 Apr 26, 2024 @ 53.91 -16.87%
Apr 03, 2024 Ga Bo   64.90 Apr 08, 2024 @ 63.34 -2.40%
Apr 02, 2024 Fer Fer fer   64.69 Apr 26, 2024 @ 53.91 +16.66%
Apr 01, 2024 채민 조   67.90 Apr 26, 2024 @ 53.91 -20.60%
Apr 01, 2024 Piero Rebosio   68.37 Apr 01, 2024 @ 66.93 -2.11%
Mar 27, 2024 Eitan Raz   70.98 Apr 01, 2024 @ 66.93 -5.71%
Mar 21, 2024 Irit Benjamin   74.16 Mar 25, 2024 @ 71.18 -4.02%
Mar 19, 2024 Jose Manuel   72.07 Apr 12, 2024 @ 60.67 -15.82%
Mar 15, 2024 FRITZ Jean Marie   72.17 Apr 05, 2024 @ 62.90 -12.84%
Mar 14, 2024 John Hilscher   75.24 Mar 18, 2024 @ 73.35 -2.51%
Mar 13, 2024 gimmyx gas   74.81 Apr 05, 2024 @ 62.90 -15.92%
Mar 13, 2024 예준 이   75.37 Apr 05, 2024 @ 62.90 -16.55%
Mar 12, 2024 Piermauro Bignotti   75.63 Apr 05, 2024 @ 62.90 -16.83%
Mar 11, 2024 oleg scherbinin   77.31 Apr 05, 2024 @ 62.90 -18.64%
Mar 07, 2024 Martin Walpen   80.85 Mar 29, 2024 @ 68.16 -15.70%
Mar 07, 2024 Florin M Pop   80.75 Mar 29, 2024 @ 68.16 -15.59%
Mar 07, 2024 John Klemmer   80.95 Mar 29, 2024 @ 68.16 -15.80%
Mar 06, 2024 Oumar Moctar   80.67 Mar 29, 2024 @ 68.16 -15.51%
Feb 29, 2024 Nabil Khalil   84.47 Mar 22, 2024 @ 71.61 -15.22%
Feb 29, 2024 Julia Rubin   84.95 Mar 22, 2024 @ 71.61 +15.70%
Feb 29, 2024 דניאל אויזרט   83.40 Mar 22, 2024 @ 71.61 -14.14%
Feb 28, 2024 Irit Benjamin   89.25 Mar 04, 2024 @ 80.81 -9.46%
Feb 27, 2024 Marius Gamissans   89.08 Mar 22, 2024 @ 71.61 -19.61%
Feb 27, 2024 Arham Humayun   86.79 Mar 22, 2024 @ 71.61 -17.49%
Feb 27, 2024 Florin M Pop   86.62 Mar 04, 2024 @ 80.81 -6.71%
Feb 26, 2024 Piero Rebosio   83.92 Feb 26, 2024 @ 84.89 +1.16%
Feb 23, 2024 Chloe Li   84.04 Mar 15, 2024 @ 72.95 -13.20%
Feb 23, 2024 סיון זמיר   83.18 Mar 15, 2024 @ 72.95 -12.30%
Feb 22, 2024 Jorge Garcia   90.28 Mar 15, 2024 @ 72.95 -19.20%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mark Nelson
Mark Nelson Jan 18, 2021 16:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock OVV and RECO (on TSXV) will all do very well this year
Mark Nelson
Mark Nelson Dec 04, 2020 13:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$200 by Christmas
Geoff Neale
Geoff Neale Dec 04, 2020 13:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2000 by Christmas next year
Mark Nelson
Mark Nelson Dec 04, 2020 13:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I was close with Jan 8, now just a slight gut check back to $200 before taking off
umair khattak
umair khattak Mar 01, 2019 15:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it wants to break through 40
umair khattak
umair khattak Mar 01, 2019 11:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like things are going good behind the scenes.
umair khattak
umair khattak Feb 27, 2019 5:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock can be a take over bait for big pharma.
umair khattak
umair khattak Sep 27, 2018 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tech of the future
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email